These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22649006)

  • 1. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
    Joutsa J; Martikainen K; Niemelä S; Johansson J; Forsback S; Rinne JO; Kaasinen V
    Mov Disord; 2012 May; 27(6):778-82. PubMed ID: 22649006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impulse control disorders in Parkinson's disease.
    Vilas D; Pont-Sunyer C; Tolosa E
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S80-4. PubMed ID: 22166463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease.
    Vitale C; Santangelo G; Trojano L; Verde F; Rocco M; Grossi D; Barone P
    Mov Disord; 2011 Apr; 26(5):830-6. PubMed ID: 21370268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
    Ceravolo R; Frosini D; Rossi C; Bonuccelli U
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between impulsivity and impulse control disorders in Parkinson's disease.
    Isaias IU; Siri C; Cilia R; De Gaspari D; Pezzoli G; Antonini A
    Mov Disord; 2008 Feb; 23(3):411-5. PubMed ID: 18067187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulse control disorders in Parkinson's disease: A cohort of 35 patients].
    Carrière N; Kreisler A; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2012 Feb; 168(2):143-51. PubMed ID: 22129474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term follow-up of Parkinson's disease patients with impulse control disorders.
    Sohtaoğlu M; Demiray DY; Kenangil G; Ozekmekçi S; Erginöz E
    Parkinsonism Relat Disord; 2010 Jun; 16(5):334-7. PubMed ID: 20223696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
    J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.
    Vallelunga A; Flaibani R; Formento-Dojot P; Biundo R; Facchini S; Antonini A
    Parkinsonism Relat Disord; 2012 May; 18(4):397-9. PubMed ID: 22113132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impotence associated with compulsive gambling.
    Daghestani AN
    J Clin Psychiatry; 1987 Mar; 48(3):115-6. PubMed ID: 3818552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of personality characteristics in Parkinson disease patients with and without impulse control disorders and in healthy volunteers.
    Farnikova K; Obereigneru R; Kanovsky P; Prasko J
    Cogn Behav Neurol; 2012 Mar; 25(1):25-33. PubMed ID: 22353727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
    Fenu S; Wardas J; Morelli M
    Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders in psychiatric inpatients.
    Müller A; Rein K; Kollei I; Jacobi A; Rotter A; Schütz P; Hillemacher T; de Zwaan M
    Psychiatry Res; 2011 Aug; 188(3):434-8. PubMed ID: 21546096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulse control disorder comorbidity among patients with bipolar I disorder.
    Karakus G; Tamam L
    Compr Psychiatry; 2011; 52(4):378-85. PubMed ID: 21683175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.
    Weintraub D; Sohr M; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
    Ann Neurol; 2010 Dec; 68(6):963-8. PubMed ID: 21154480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders and dopaminergic treatments in Parkinson's disease.
    Villa C; Pascual-Sedano B; Pagonabarraga J; Kulisevsky J
    Rev Neurol (Paris); 2011 Nov; 167(11):827-32. PubMed ID: 21596410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
    Weintraub D
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome.
    Dang D; Cunnington D; Swieca J
    Clin Neuropharmacol; 2011; 34(2):66-70. PubMed ID: 21412200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.